Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Sabadilla
Brand Name
Sabadilla
Generic Name
Sabadilla
Active Ingredient
Schoenocaulon Officinale SeedCategory
Standardized Insect Venom Allergenic Extract [EPC]
Variants
8
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 12 [hp_C]/1 | PELLET | ORAL | 37662-1216 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-1217 |
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-1222 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Sabadilla, you must consult a qualified healthcare professional.
| 100 [hp_C]/1 | PELLET | ORAL | 37662-1218 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-1220 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-1221 |
| 6 [hp_C]/1 | PELLET | ORAL | 37662-1215 |
| 200 [hp_C]/1 | PELLET | ORAL | 37662-1219 |
Detailed information about Sabadilla
Schoenocaulon Officinale Seed, also known as Sabadilla, is a botanical extract classified as a Standardized Insect Venom Allergenic Extract and an Adrenergic Agonist. It is primarily used in allergy immunotherapy and specific respiratory or dermatological formulations.
Dosage for Schoenocaulon Officinale Seed varies significantly depending on the indication and the concentration of the extract.
Schoenocaulon Officinale Seed may be used in children, but with extreme caution.
While the primary elimination is renal, specific dose adjustment scales for GFR (Glomerular Filtration Rate) are not standardized for allergenic extracts. However, patients with severe renal failure should be monitored for potential alkaloid accumulation if systemic absorption occurs. Healthcare providers may choose to extend the interval between doses in patients with Stage 4 or 5 Chronic Kidney Disease.
Patients with significant hepatic dysfunction (Child-Pugh Class B or C) may experience slower metabolism of the veratrine alkaloids. In these cases, the build-up phase of immunotherapy should proceed more slowly, with careful monitoring for signs of CNS stimulation or cardiovascular stress.
Geriatric patients often have increased sensitivity to adrenergic agonists. Dosing should start at the lowest possible end of the spectrum. Special attention must be paid to heart rate and blood pressure, as Schoenocaulon Officinale Seed can induce tachycardia (fast heart rate) or hypertension in sensitive individuals.
If a dose of an allergenic extract is missed during the build-up phase, the next dose may need to be reduced to ensure safety. If more than two weeks have passed since the last injection, consult your allergist; you may need to restart at a lower concentration. For oral or nasal forms, take the missed dose as soon as remembered, unless it is nearly time for the next dose. Do not double the dose to catch up.
Signs of overdose with Schoenocaulon Officinale Seed include intense sneezing, burning of the mucous membranes, severe vomiting, diarrhea, muscle weakness, bradycardia (slow heart rate) followed by tachycardia, and respiratory distress. In severe cases, it can lead to hypotension and convulsions due to the alkaloid content.
Emergency Measures: If an overdose is suspected, contact a Poison Control Center or seek emergency medical care immediately. Treatment is primarily supportive, focusing on maintaining airway patency and cardiovascular stability. Atropine may be considered by medical professionals if severe bradycardia occurs.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without explicit medical guidance, as this increases the risk of a life-threatening allergic reaction.
Patients taking Schoenocaulon Officinale Seed, particularly in nasal or injectable forms, frequently report localized reactions. These include:
Schoenocaulon Officinale Seed is a potent biological and pharmacological agent. It must be handled with care, especially in its concentrated form. The alkaloids contained within the seed are toxic in high doses and can affect the nervous and cardiovascular systems. Patients must ensure they are receiving the correct concentration and that the product has been stored according to manufacturer guidelines to prevent degradation or unintended potency changes.
As noted in the side effects section, the primary Black Box Warning for Schoenocaulon Officinale Seed (as an allergenic extract) concerns the risk of Anaphylaxis. According to FDA-approved labeling for standardized extracts (2024), this risk is highest during the build-up phase of treatment and in patients with pre-existing respiratory compromise. The warning emphasizes that the medication is contraindicated in patients with severe, unstable, or uncontrolled asthma due to the risk of fatal bronchospasm.
Schoenocaulon Officinale Seed must NEVER be used in the following circumstances:
FDA Pregnancy Category: C (based on historical standards).
There are no adequate and well-controlled studies of Schoenocaulon Officinale Seed in pregnant women. Animal reproduction studies have not been conducted. The primary risk during pregnancy is not direct teratogenicity (birth defects) from the alkaloids, but rather the risk of maternal anaphylaxis. A severe allergic reaction can cause a sudden drop in blood pressure and uterine contraction, leading to fetal hypoxia (lack of oxygen) or miscarriage.
It is not known whether the alkaloids or the allergenic proteins from Schoenocaulon Officinale Seed are excreted in human milk. Because many drugs are excreted in milk and the potential for systemic effects in the infant (such as irritability or tachycardia) exists, caution should be exercised. Most experts consider the risk to be low when the drug is used in standardized, low-dose immunotherapy, but the nursing infant should be monitored for any unusual changes in sleep patterns or heart rate.
Schoenocaulon Officinale Seed exerts its effects through a complex interaction with several biological systems:
Common questions about Sabadilla
Schoenocaulon Officinale Seed, also known as Sabadilla, is primarily used in the field of allergy and immunology as a standardized allergenic extract. Healthcare providers use it to diagnose specific allergies through skin testing and to treat them via immunotherapy (allergy shots) to desensitize the immune system. Additionally, due to its adrenergic properties, it is used in some formulations to relieve symptoms of hay fever, such as intense sneezing and nasal congestion. It works by modulating the body's response to allergens and stimulating receptors that cause vasoconstriction in the nasal passages. Historically, it was also used topically for treating head lice, though this is less common today. Always consult an allergist to see if this extract is appropriate for your specific allergy profile.
The most frequently reported side effect of Schoenocaulon Officinale Seed, especially when used in nasal sprays or inhaled, is intense, paroxysmal sneezing. This occurs because the alkaloids in the seed irritate the sensory nerve endings in the nose. Other common side effects include localized redness, itching, or swelling at the site of an immunotherapy injection. Patients may also experience watery eyes, a runny nose, or a mild headache shortly after administration. These reactions are typically short-lived and resolve without medical intervention. However, if these symptoms become severe or are accompanied by hives and difficulty breathing, they may indicate a more serious allergic reaction.
It is strongly recommended to avoid alcohol consumption for at least 24 hours before and after receiving an injection of Schoenocaulon Officinale Seed allergenic extract. Alcohol can cause blood vessels to dilate, which may increase the rate at which the extract is absorbed into your system, potentially increasing the risk of a systemic reaction. Furthermore, alcohol can mask the early symptoms of anaphylaxis, such as dizziness or flushing, making it harder for you or your doctor to recognize a medical emergency. For those using low-dose oral or nasal forms, moderate alcohol consumption may be less risky, but it can still exacerbate nasal congestion. Always discuss your lifestyle habits with your prescribing physician.
Schoenocaulon Officinale Seed is generally approached with caution during pregnancy, primarily due to the risk of anaphylaxis. While the drug itself is not known to cause birth defects, a severe allergic reaction in the mother can lead to a dangerous drop in blood pressure and oxygen delivery to the fetus. Most allergists will not start a new course of immunotherapy for a pregnant patient. If you are already on a maintenance dose and become pregnant, your doctor may choose to continue the treatment but will likely not increase the dosage until after delivery. Always inform your healthcare provider immediately if you become pregnant while using this medication.
The timeframe for Schoenocaulon Officinale Seed to work depends on the form being used. For immediate symptom relief from nasal congestion, the adrenergic effects typically begin within 15 to 30 minutes of application. However, when used for its primary purpose in allergy immunotherapy, the process is much slower. It usually takes 3 to 6 months of weekly 'build-up' injections before you notice a significant reduction in your allergy symptoms. Full effectiveness and long-term immune system retraining often require a commitment of 3 to 5 years of maintenance therapy. Consistency is key to achieving the desensitization benefits of this extract.
If you are using Schoenocaulon Officinale Seed for allergy immunotherapy, stopping suddenly will cause your immune system to lose the progress it has made toward desensitization. This means your allergies will likely return to their previous severity over time. If you miss multiple doses, you cannot simply resume at your previous dose; your doctor will need to restart you at a lower, safer concentration to prevent a reaction. For nasal sprays or oral pellets used for temporary relief, you can stop at any time without withdrawal symptoms, though your hay fever symptoms may reappear. Always consult your allergist before making changes to your treatment schedule.
If you miss an appointment for an immunotherapy injection, contact your allergist's office immediately to reschedule. The safety of the next dose depends on how much time has passed since your last injection; if too much time has elapsed, the dose may need to be reduced to avoid an allergic reaction. For oral or nasal forms, take the missed dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue with your regular routine. Never take a double dose to make up for a missed one, as this significantly increases the risk of alkaloid toxicity or a systemic allergic response.
There is currently no clinical evidence to suggest that Schoenocaulon Officinale Seed causes weight gain. Unlike some other allergy treatments, such as oral corticosteroids, this extract does not interfere with metabolic processes or increase appetite in a way that leads to fat accumulation. Its primary actions are limited to the immune system and the adrenergic receptors. If you experience unexpected weight changes while on this medication, it is likely due to other factors or medications. Discuss any concerns about weight with your healthcare provider to identify the underlying cause.
Schoenocaulon Officinale Seed can interact with several types of medications, some of which are very common. It is particularly dangerous to take with beta-blockers, which are often prescribed for heart conditions or high blood pressure, because they can make a severe allergic reaction much harder to treat. It may also interact with MAO inhibitors and certain antidepressants, leading to dangerous spikes in blood pressure. Even over-the-counter decongestants can have additive effects with this seed extract, causing heart palpitations or jitteriness. Always provide your doctor with a full list of all medications, including vitamins and herbal supplements, before starting treatment.
Schoenocaulon Officinale Seed is typically available as a standardized botanical extract rather than a traditional 'generic' drug. In the world of allergenic extracts, products are often produced by specialized biological laboratories and may be marketed under various brand names or simply by their scientific name. While there may be different manufacturers of Sabadilla or Schoenocaulon extracts, they are not interchangeable in the same way generic ibuprofen is for Advil. Each manufacturer's extract may have slightly different potencies. Therefore, it is important to stay with the same brand and concentration throughout your treatment unless your doctor specifically directs a change.
Other drugs with the same active ingredient (Schoenocaulon Officinale Seed)
> Warning: Stop using Schoenocaulon Officinale Seed and call your doctor or emergency services immediately if you experience any of the following:
With prolonged use of Schoenocaulon Officinale Seed in immunotherapy, patients may develop a long-term 'tolerance' to the allergen, which is the desired therapeutic effect. However, chronic irritation of the nasal mucosa from nasal sprays can lead to thinning of the mucosal lining or chronic dryness. There is no evidence currently suggesting that long-term use leads to organ toxicity, provided the dosing remains within the standardized clinical ranges.
Schoenocaulon Officinale Seed, when used as an allergenic extract, can cause severe, life-threatening systemic allergic reactions, including anaphylaxis.
Report any unusual symptoms, especially those affecting your breathing or heart rate, to your healthcare provider immediately. Even minor symptoms like an itchy throat or palms can be early warning signs of a systemic reaction.
Schoenocaulon Officinale Seed may cause dizziness or fatigue, particularly after an injection or if systemic absorption occurs. Patients should avoid driving or operating heavy machinery until they know how the medication affects them. If you feel lightheaded or 'spaced out' after a dose, wait until the feeling passes completely before attempting these activities.
Alcohol can cause vasodilation and may increase the rate of absorption of the alkaloids or worsen the symptoms of an allergic reaction. It is generally advised to avoid alcohol for at least 24 hours surrounding an immunotherapy injection. Alcohol can also mask the early signs of anaphylaxis, making it more dangerous.
Do not stop immunotherapy abruptly without consulting your allergist, as this will result in a loss of the desensitization achieved. If the medication is being used for symptomatic relief (nasal/oral), it can usually be stopped without a tapering schedule, though symptoms of the underlying allergy may return quickly.
> Important: Discuss all your medical conditions, especially heart disease, asthma, and thyroid disorders, with your healthcare provider before starting Schoenocaulon Officinale Seed.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential to prevent dangerous pharmacological overlaps.
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to other members of the lily family (Liliaceae) or specifically the genus Veratrum (False Hellebore) may exhibit cross-sensitivity to Schoenocaulon Officinale Seed. Furthermore, because it is classified as a Standardized Insect Venom Allergenic Extract [EPC], patients with known severe allergies to honeybee, wasp, or hornet venom should be monitored with extreme caution, as the extract may be used in cross-desensitization protocols or contain related protein structures.
> Important: Your healthcare provider will evaluate your complete medical history, including your current lung function and heart health, before prescribing Schoenocaulon Officinale Seed.
Schoenocaulon Officinale Seed is approved for use in children as part of allergenic extracts, typically for those aged 6 and older.
Patients over the age of 65 may have reduced physiological reserves to handle a systemic reaction.
In patients with impaired renal function, the excretion of veratrine metabolites may be delayed. While no specific GFR-based dosing table exists, a 25-50% reduction in the frequency of dose escalation during the build-up phase is often recommended for patients with a GFR < 30 mL/min.
Since the liver is the primary site of alkaloid metabolism, patients with cirrhosis or hepatitis should be monitored for signs of alkaloid toxicity (e.g., excessive sneezing, tremors, or bradycardia). In severe hepatic impairment, the use of concentrated extracts may be contraindicated.
> Important: Special populations require individualized medical assessment. Always inform your specialist about your pregnancy status or any age-related health concerns.
| Parameter | Value |
|---|---|
| Bioavailability | 15-30% (Oral); High (Subcutaneous) |
| Protein Binding | ~45-60% |
| Half-life | 2-6 hours (Alkaloids) |
| Tmax | 1-3 hours |
| Metabolism | Hepatic (CYP3A4 involvement) |
| Excretion | Renal 70%, Fecal 20% |
Schoenocaulon Officinale Seed is classified as a Standardized Allergenic Extract and a Sympathomimetic (Adrenergic Agonist). It is related to other botanical alkaloids like those found in Veratrum album, but its specific use in insect venom and plant allergenic extracts makes it unique in the immunology pharmacopeia.